Beactica AB Company

Beactica is a drug discovery company utilising its proprietary methodologies to evaluate the interaction of molecules in order to generate novel therapeutics. They offer expertise and services in the area of SPR biosensor-based small molecule interaction analysis and partnerships for fragment-based lead generation using their proprietary Sprint™ platform. Founded in 2006 based on research carried out at Uppsala University and first-hand experience from the drug discovery industry, Beactica has established a robust reputation as the leader in SPR biosensor-based small molecule drug discovery. As well as providing services and building collaborations with external companies, Beactica is progressing its own drug discovery programmes.
Technology: Others
Industry: Health Care
Headquarters: Uppsala, Uppsala Lan, Sweden
Founded Date: 2006-01-01
Employees Number: 11-50
Investors Number: 1
Total Funding: SEK4M
Estimated Revenue: Less than $1M
Last Funding Type: Venture - Series Unknown

Visit Website
https://www.twitter.com/beactica
Register and Claim Ownership